4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-022242
Chief Medical Officer sold 407 shares at $25.00 ($10,175)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-02-28 | Sale 10b5-1 | −407 | $25.00 | $10,175 | 163,096 | D: show line 1 in the form |
| Open-market sales · 407 sh · avg $25.00 · $10,175 | |||||||
Loading xslF345X05/ownership.xml…